NCT01435057

Brief Summary

In this project, the investigators will test the hypothesis that predominant (two to three times a week 60 min) strength training is more effective in reducing visceral fat mass than endurance training in obese patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 11, 2011

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 15, 2011

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

May 28, 2015

Status Verified

May 1, 2015

Enrollment Period

4.8 years

First QC Date

May 11, 2011

Last Update Submit

May 27, 2015

Conditions

Keywords

Abdominal Obesitytrainingfatinsulinglucosediet

Outcome Measures

Primary Outcomes (1)

  • MRI

    Change from Baseline in abdominal visceral fat area as determined by MRI scans at the level of L4-L5 after 12 months of training intervention

    Baseline and after 12 months after randomisation

Secondary Outcomes (8)

  • MRI

    Baseline, 12 and 24 months after randomisation

  • BIA

    Baseline, 6, 12, 18 and 24 months after randomisation

  • compliance to the intervention

    over 24 months of intervention

  • well being as measured by SF-36

    Baseline and every 6 months during intervention

  • indirect calorimetry

    Baseline, 6, 12, 18 and 24 months after randomisation

  • +3 more secondary outcomes

Study Arms (2)

endurance training

ACTIVE COMPARATOR

Endurance training: Supervised, twice a week, each training session consists of a 20 min warm up and cool down period and a minimum of 40min tread mill, rawing device or bicycle training. During the study period of 24 months, we will perform an open randomized, prospective training intervention study comparing the effects of three times a week either strength or endurance training on reduction of visceral fat area as determined by MRI scans at the level of L4-L5.

Procedure: exercise training

strength training

ACTIVE COMPARATOR

Strength training: Supervised, twice a week, each training session consists of a 20 min warm up and cool down period and a minimum of 40min circle training During the study period of 24 months, we will perform an open randomized, prospective training intervention study comparing the effects of two to three times a week either strength or endurance training on reduction of visceral fat area as determined by MRI scans at the level of L4-L5.

Procedure: exercise training

Interventions

comparison of strength versus endurance training (two or three times a week, 60 minutes per training session) over 24 months

endurance trainingstrength training

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • BMI \>= 35 kg/m2
  • waist circumference \>102cm (men), \>88cm (women)
  • age 18 - 60 years
  • written informed consent

You may not qualify if:

  • type 1 or type 2 diabetes
  • fasting plasma glucose \>= 6.0 mmol/l
  • h-OGTT (oral glucose tolerance test) glucose \>= 11.1 mmol/l
  • any chronic inflammatory or malignant disease
  • medical treatment which influences glucose metabolism
  • drug or alcohol abuse
  • psychiatric disorders
  • untreated thyroid dysfunction
  • cardiac pacemaker or other contraindication for MRI
  • attendant therapy with oral antidiabetic medication, GLP-1 mimetics or analoga, Insulin, anti-obesity medication (orlistat, sibutramine), Falithrom, antipsychotic drugs, any chemotherapeutics
  • pregnant or nursing women
  • expected low compliance
  • current participation in another investigational trial
  • last exercise training \<= 6 months ago

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Leipzig, Department of Medicine

Leipzig, Saxony, 04103, Germany

RECRUITING

MeSH Terms

Conditions

Obesity, AbdominalPlatelet Glycoprotein IV DeficiencyInsulin Resistance

Interventions

Exercise

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Matthias Blüher, prof., MD

    University of Leipzig

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

May 11, 2011

First Posted

September 15, 2011

Study Start

April 1, 2011

Primary Completion

January 1, 2016

Study Completion

April 1, 2016

Last Updated

May 28, 2015

Record last verified: 2015-05

Locations